74 related articles for article (PubMed ID: 19081178)
61. HDM2 antagonist Nutlin-3 disrupts p73-HDM2 binding and enhances p73 function.
Lau LM; Nugent JK; Zhao X; Irwin MS
Oncogene; 2008 Feb; 27(7):997-1003. PubMed ID: 17700533
[TBL] [Abstract][Full Text] [Related]
62. Nutlin-3, an Hdm2 antagonist, inhibits tumor adaptation to hypoxia by stimulating the FIH-mediated inactivation of HIF-1alpha.
Lee YM; Lim JH; Chun YS; Moon HE; Lee MK; Huang LE; Park JW
Carcinogenesis; 2009 Oct; 30(10):1768-75. PubMed ID: 19696166
[TBL] [Abstract][Full Text] [Related]
63. Inhibition of p53-murine double minute 2 interaction by nutlin-3A stabilizes p53 and induces cell cycle arrest and apoptosis in Hodgkin lymphoma.
Drakos E; Thomaides A; Medeiros LJ; Li J; Leventaki V; Konopleva M; Andreeff M; Rassidakis GZ
Clin Cancer Res; 2007 Jun; 13(11):3380-7. PubMed ID: 17545546
[TBL] [Abstract][Full Text] [Related]
64. Small molecule inhibition of HDM2 leads to p53-mediated cell death in retinoblastoma cells.
Elison JR; Cobrinik D; Claros N; Abramson DH; Lee TC
Arch Ophthalmol; 2006 Sep; 124(9):1269-75. PubMed ID: 16966622
[TBL] [Abstract][Full Text] [Related]
65. Levels of HdmX expression dictate the sensitivity of normal and transformed cells to Nutlin-3.
Patton JT; Mayo LD; Singhi AD; Gudkov AV; Stark GR; Jackson MW
Cancer Res; 2006 Mar; 66(6):3169-76. PubMed ID: 16540668
[TBL] [Abstract][Full Text] [Related]
66. Reactivation of p53 function in synovial sarcoma cells by inhibition of p53-HDM2 interaction.
D'Arcy P; Ryan BA; Brodin B
Cancer Lett; 2009 Mar; 275(2):285-92. PubMed ID: 19081178
[TBL] [Abstract][Full Text] [Related]
67. Helping the Released Guardian: Drug Combinations for Supporting the Anticancer Activity of HDM2 (MDM2) Antagonists.
Kocik J; Machula M; Wisniewska A; Surmiak E; Holak TA; Skalniak L
Cancers (Basel); 2019 Jul; 11(7):. PubMed ID: 31331108
[TBL] [Abstract][Full Text] [Related]
68. Therapeutic potential of p53 reactivation in cervical cancer.
Zhao X; Sun W; Ren Y; Lu Z
Crit Rev Oncol Hematol; 2021 Jan; 157():103182. PubMed ID: 33276182
[TBL] [Abstract][Full Text] [Related]
69.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
70.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
71.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
72.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
73.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
74.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [New Search]
